today announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients with PROC in an oral presentation at the Society of Gynecologic Oncology (SGO ...

The 2025 Society of Gynecologic Oncology Annual Meeting highlighted key advancements in endometrial cancer treatment, emphasizing individualized therapies. Dr Kathleen Moore discussed promising ...

Toon Van Gorp, MD, PhD, discusses the rationale behind and the findings from the phase 3 MIRASOL trial of mirvetuximab soravtansine in patients with folate receptor α–positive, platinum-resistant ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

University of Kentucky Markey Cancer Center researchers presented ... approach to ovarian cancer maintenance therapy at the Society of Gynecologic Oncology annual meeting in Seattle (SGO 2025).

including an oral presentation with updated clinical data from the ongoing Phase 2 DENALI clinical trial of azenosertib in patients with platinum-resistant ovarian cancer (PROC), at the Society of ...